研究者情報
検索ページ

（最終更新日：2025-04-11 16:32:49）   ミヤベ ヨシシゲ   MIYABE YOSHISHIGE   宮部斉重    所属   医学部医学科 免疫学・病害動物学    職種   主任教授

■ 学術雑誌 1. 総説・解説　 Chemokines as therapeutic targets for multiple sclerosis: a spatial and chronological perspective 2025/03 2. 原著　 Clodronate liposome treatment contributes to the nerve regeneration in corneal nerve involvement of diabetic mice 2025/01 3. 原著　 Microbial alpha diversity in the intestine negatively correlated with disease duration in patients with Meniere's disease 2024/12 4. 原著　 Combination of plasma MMPs and PD-1-binding soluble PD-L1 predicts recurrence in gastric cancer and the efficacy of immune checkpoint inhibitors in non-small cell lung cancer 2024/05 5. 原著　 Lysosomal degradation of PD-L1 is associated with immune-related adverse events during anti-PD-L1 immunotherapy in NSCLC patients 2024/05 6. 総説・解説　 Streptococcal infection and autoimmune diseases 2024/02 7. 原著　 Alteration of microbial composition in the skin and blood in vasculitis 2023/09 8. 総説・解説　 Innate immune responses in Behçet disease and relapsing 2023/06 9. 総説・解説　 Chemokines and chemokine receptors as promising targets in rheumatoid arthritis 2023/02 10. 原著　 Nephritis-associated plasmin receptor in the cutaneous vessels in IgA vasculitis 2023/01 11. 原著　 Nephritis-associated plasmin receptor in the cutaneous vessels in IgA vasculitis 2022/09 12. 総説・解説　 Immunopathology of Behcet's Disease: An Overview of the Metagenomic Approaches 2022/08 13. 原著　 Avacopan for the Treatment of ANCA-Associated Vasculitis 2021 14. 総説・解説　 Pathogens in vasculitis: is it really idiopathic? 2021 15. 総説・解説　 Targeting the chemoattractant system in inflammation. 2021 16. 原著　 Astrocyte- and neuron-derived CXCL1 drives neutrophil transmigration and blood-brain barrier permeability in viral encephalitis. 2020 17. 総説・解説　 関節内インビボイメージングを用いた関節炎病態の解明. 2020 18. 原著　 Abrogation of Lysophosphatidic Acid Receptor 1 Ameliorates Murine Vasculitis. 2019 19. 原著　 Atypical complement receptor C5aR2 transports C5a to initiate neutrophil adhesion and inflammation. 2019 20. 総説・解説　 Chemokines in Rheumatic Diseases and Therapeutic Implications. 2019 21. 原著　 Dectin-2 induced CCL2 production in tissue-resident macrophages ignites cardiac arteritis. 2019 22. 原著　 CXCL10 stabilizes T cell-brain endothelial cell adhesion leading to the induction of cerebral malaria. 2018 23. 原著　 Directed evolution of proteins with exceptional binding promiscuity and superior therapeutic efficacy. 2018 24. 総説・解説　 The critical role of C5a as an initiator of neutrophil-mediated autoimmune Inflammation of the joint and skin. 2018 25. 原著　 A sphingosine 1-phosphate receptor agonist ameliorates animal model of vasculitis. 2017 26. 原著　 An expanded population of pathogenic regulatory T-cells in giant cell arteritis is abrogated by IL-6 blockade therapy. 2017 27. 原著　 Complement C5a Receptor is the Key Initiator of Neutrophil Adhesion Igniting Immune Complex-induced Arthritis. 2017 28. 原著　 Studying Chemokine Control of Neutrophil Migration In Vivo in a Murine Model of Inflammatory Arthritis. 2016 29. 原著　 Studying Neutrophil Migration In Vivo Using Adoptive Cell Transfer. 2016 30. 総説・解説　 Could retinoids be a potential treatment for rheumatic diseases? 2015 31. 総説・解説　 LTB4 and BLT1 in inflammatory arthritis. 2015 32. 原著　 Activation of fibroblast-like synoviocytes derived from rheumatoid arthritis via lysophosphatidic acid-lysophosphatidic acid receptor 1 cascade. 2014 33. 原著　 Cannabinoid receptor 2 as a potential therapeutic target in rheumatoid arthritis. 2014 34. 総説・解説　 関節炎の発症にLPA/LPA1シグナルが必要である. 2014 35. 原著　 Am80, a retinoic acid receptor agonist, ameliorates murine vasculitis through the suppression of neutrophil migration and activation 2013 36. 原著　 CCL18 activates fibroblast-like synoviocytes in patients with rheumatoid arthritis. 2013 37. 原著　 Necessity of lysophosphatidic acid receptor 1 for development of arthritis. 2013 38. 総説・解説　 RA滑膜細胞上のリゾフォスファチジン酸レセプターの意義. 2013 39. 症例報告　 Polymyositis in a father and his son; a case report. 2012 40. 原著　 Chemerin activates fibroblast-like synoviocytes in patients with rheumatoid arthritis 2011 41. 症例報告　 Microscopic polyangiitis with renal mass-like lesion: a case report. 2011 42. 症例報告　 Prominent splenic microcalcifications in a patient with systemic lupus erythematosus complicated by antiphospholipid syndrome. 2011 43. 症例報告　 Successful treatment of cyclosporine-A-resistant cytophagic histiocytic panniculitis with tacrolimus. 2011 44. 総説・解説　 関節リウマチにおけるCCL19,CCL21の役割. 2011 45. 原著　 Pathogenic role of CXCR7 in rheumatoid arthritis 2010 46. 症例報告　 Successful treatment of interstitial pneumonia and pneumomediastinum associated with polymyositis during pregnancy with a combination of cyclophosphamide and tacrolimus: A case report. 2010 5件表示 全件表示(46件)

■ 学会発表 1. The potential of plasma CXCL10 as a biomarker that reflects pathogenesis and prognosis in systemic chronic active EBV disease （ポスター，一般） 2024/12/08 2. 全身性慢性活動性EBウイルス病の診断と治療効果判 定におけるCXCL10 の意義 （口頭発表，一般） 2024/10/12 3. 全身性慢性活動性EBウイルス病の診断と治療効果判定におけるCXCL10の意義 （口頭発表，一般） 2024/10/12 4. Preliminary study for three-dimensional tissue regeneration of nerve tissue using porous apatite-fiber scaffold （ポスター，一般） 2024/10 5. In vivo imaging of Colon Reveals Leukocyte Migratory Behavior in Inflammatory Bowel Diseases （ポスター，一般） 2024/06/07 6. 水酸アパタイトセラミックスを用いたマウス神経芽株化細胞の培養およびその評価 （ポスター，一般） 2024/06/07 7. 血管炎における血清と皮膚の微生物叢の変化 （ポスター，一般） 2024/04/18 8. 慢性活動性EBウイルス病に対するアレムツズマブの有効性の検証 （口頭発表，一般） 2023/10/15 9. Gut microbe metabolite short-chain fatty acids may associate with development of respiratory involvement in patients with relapsing polychondritis. （口頭発表，シンポジウム・ワークショップ・パネルディスカッション等） 2022/11/10 10. 免疫チェックポイント阻害剤抗PD-1抗体および抗PD-L1抗体投与後の生体内局在 （ポスター，一般） 2022/11/09 11. 関節でのⅢ型アレルギー反応機序における補体の新規機能の解析 （口頭発表，一般） 2022/08/20 5件表示 全件表示(11件)